Loading...
•
Sep 30, 2025
Ultralife Q3 2025 Earnings Report
Ultralife reported a net loss of $1.2 million on revenue of $43.4 million for Q3 2025, driven by non-recurring costs and lower margins.
Key Takeaways
Ultralife Corporation posted a quarterly net loss despite higher sales, as one-time charges and manufacturing inefficiencies weighed on profitability.
Revenue rose 21.5% year-over-year to $43.4 million, boosted by the Electrochem acquisition.
Net loss of $1.2 million due to $1.1 million in one-time non-recurring expenses.
Gross margin declined to 22.2% from 24.3% due to manufacturing inefficiencies.
Adjusted EBITDA increased slightly to $2.0 million from $1.9 million a year ago.
Revenue by Segment
Forward Guidance
Ultralife aims to boost operational efficiency and capitalize on a strong product pipeline despite current supply chain and cost challenges.
Positive Outlook
- Continued investment in lean and process improvement initiatives.
- Closure of Calgary facility expected to save $800,000 annually.
- Strong demand from a U.S.-based global prime in defense segment.
- New product development entering qualification and production stages.
- Backlog increased to $90.1 million from $84.5 million last quarter.
Challenges Ahead
- Supply chain issues caused manufacturing inefficiencies.
- Lower gross margin impacted by raw material quality issues.
- Non-recurring costs totaling $1.1 million impacted profitability.
- Continued delays in Communications Systems orders.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...